Alumis Inc.
ALMS
$9.90
-$0.69-6.47%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
4/10/2025
-
MarketBeat
9/9/2026
-
Insider Monkey
9/7/2026
-
Simply Wall St
9/5/2026
-
MarketBeat
9/4/2026
-
SeekingAlpha
9/4/2026
-
Globe Newswire
9/4/2026
-
Simply Wall St
9/3/2026
-
The Cerbat Gem
9/3/2026
-
MarketBeat
9/3/2026
-
TipRanks
9/3/2026
-
Seeking Alpha - Healthcare
9/3/2026
-
TipRanks: TheFly
9/2/2026
-
TipRanks: TheFly
9/2/2026
-
MarketBeat
9/2/2026
-
Benzinga
9/2/2026
-
MarketBeat
9/2/2026
-
TipRanks: TheFly
9/2/2026
-
TipRanks: TheFly
9/2/2026
-
TipRanks: TheFly
9/2/2026
-
TipRanks
9/2/2026
-
TipRanks: TheFly
9/1/2026
-
SeekingAlpha
9/1/2026
-
Seeking Alpha - Long Ideas
9/1/2026
-
TipRanks: TheFly
9/1/2026
-
Stock Options Channel
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 13, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 231 6625
Address
280 East Grand Avenue
South San Francisco, CA 94080
South San Francisco, CA 94080
Country
Year Founded
Business Description
Sector
Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine...
more